Afatinib Impurity 37 | CAS 2223677-61-8 - Request Quote
Afatinib Impurity 37
| SZ CAT No: | SZ-A054061 |
| CAS No | 2223677-61-8 |
| Mol.F. | C20H19ClFN5O2 |
| Mol.Wt. | 415.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Afatinib Impurity 37 is chemically (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide. Afatinib Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Afatinib Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2223677-61-8
Purchase 2223677-61-8
Order 2223677-61-8
Enquire 2223677-61-8
price of 2223677-61-8
2223677-61-8 Supplier
2223677-61-8 Manufacturer
2223677-61-8 Exporter
buy high quality Afatinib Impurity 37
Purchase Afatinib Impurity 37
Afatinib Impurity 37 suppliers
Afatinib Impurity 37 manufacturers
Afatinib Impurity 37 price
Order Afatinib Impurity 37
Enquire Afatinib Impurity 37
Afatinib Impurity 37 cost
Afatinib Impurity 37 Supplier
Afatinib Impurity 37 Distributor
Afatinib Impurity 37 for Method Validation
Afatinib Reference Standard
Afatinib Impurity 37 for ANDA Filing
Afatinib Impurity 37 for Forced Degradation Studies
Afatinib Impurity 37 Identification Standards
Afatinib Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.